BERTAZZONI MINELLI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 21.181
EU - Europa 15.159
AS - Asia 10.536
SA - Sud America 1.351
Continente sconosciuto - Info sul continente non disponibili 349
AF - Africa 173
OC - Oceania 39
Totale 48.788
Nazione #
US - Stati Uniti d'America 20.638
SG - Singapore 4.780
RU - Federazione Russa 4.233
GB - Regno Unito 3.602
CN - Cina 3.010
IT - Italia 2.317
BR - Brasile 1.095
FR - Francia 944
SE - Svezia 935
DE - Germania 916
VN - Vietnam 710
FI - Finlandia 696
IE - Irlanda 670
HK - Hong Kong 633
KR - Corea 340
UA - Ucraina 335
CA - Canada 258
BD - Bangladesh 169
JP - Giappone 166
IN - India 132
NL - Olanda 115
TR - Turchia 96
AR - Argentina 92
BE - Belgio 73
IQ - Iraq 61
PL - Polonia 61
ES - Italia 60
MX - Messico 58
SA - Arabia Saudita 56
ID - Indonesia 55
PK - Pakistan 46
CR - Costa Rica 40
IR - Iran 40
IL - Israele 39
EC - Ecuador 38
ZA - Sudafrica 36
CO - Colombia 35
AU - Australia 32
GT - Guatemala 31
UZ - Uzbekistan 28
NI - Nicaragua 26
MA - Marocco 24
TT - Trinidad e Tobago 23
SV - El Salvador 22
CL - Cile 21
PE - Perù 21
RO - Romania 21
CW - ???statistics.table.value.countryCode.CW??? 20
HN - Honduras 20
KE - Kenya 20
LT - Lituania 20
VE - Venezuela 20
CH - Svizzera 19
NG - Nigeria 19
NP - Nepal 19
EG - Egitto 17
AT - Austria 16
KZ - Kazakistan 16
PR - Porto Rico 16
AE - Emirati Arabi Uniti 15
CZ - Repubblica Ceca 15
MY - Malesia 15
PH - Filippine 15
BG - Bulgaria 14
JO - Giordania 14
TN - Tunisia 14
DZ - Algeria 13
JM - Giamaica 13
PY - Paraguay 13
SC - Seychelles 13
OM - Oman 12
AZ - Azerbaigian 10
BO - Bolivia 10
BY - Bielorussia 10
DK - Danimarca 10
GP - Guadalupe 10
PA - Panama 9
PT - Portogallo 9
EE - Estonia 8
EU - Europa 8
HU - Ungheria 8
AM - Armenia 7
GR - Grecia 7
LB - Libano 7
NZ - Nuova Zelanda 7
RS - Serbia 7
AL - Albania 6
BB - Barbados 6
HR - Croazia 6
QA - Qatar 6
TH - Thailandia 6
ET - Etiopia 5
GE - Georgia 5
UY - Uruguay 5
KG - Kirghizistan 4
LK - Sri Lanka 4
LV - Lettonia 4
MK - Macedonia 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
Totale 48.413
Città #
Ashburn 3.147
Southend 3.035
Jacksonville 2.934
Singapore 2.662
Chandler 2.068
San Jose 1.313
Moscow 1.145
Woodbridge 1.129
Dallas 944
Ann Arbor 758
Dublin 669
Council Bluffs 649
Hong Kong 616
Verona 586
Houston 560
The Dalles 501
Lawrence 320
Princeton 320
Beijing 306
Wilmington 303
Nanjing 288
New York 273
Ho Chi Minh City 259
Los Angeles 244
Sindelfingen 240
Jinan 215
Providence 210
Shenyang 198
Boardman 191
Buffalo 173
São Paulo 169
Milan 162
Tokyo 161
Hanoi 159
Hebei 140
Tianjin 140
Santa Clara 139
Helsinki 138
Munich 119
Rome 109
Zhengzhou 101
Changsha 97
Ningbo 96
Nanchang 95
Toronto 80
Haikou 78
Brussels 71
Frankfurt am Main 71
Hangzhou 68
Orem 67
Jiaxing 66
Guangzhou 63
Seattle 63
Taizhou 60
Atlanta 57
Norwalk 54
Taiyuan 53
Chicago 50
Naples 46
San Francisco 46
Lanzhou 41
Redondo Beach 41
Montreal 40
Columbus 37
Da Nang 37
Chennai 36
London 36
Amsterdam 34
Fairfield 34
Rio de Janeiro 33
Phoenix 32
Belo Horizonte 31
Fuzhou 31
Warsaw 31
San José 30
Turku 30
Annandale 28
Brooklyn 28
Las Vegas 28
Philadelphia 28
Edinburgh 27
Stockholm 27
Turin 27
Manchester 26
Tashkent 26
Riyadh 25
Baghdad 24
Barnet 24
Bologna 24
Denver 24
Florence 24
Guatemala City 24
Haiphong 24
Managua 24
Redwood City 24
Brasília 23
Washington 23
Boston 22
San Diego 22
Johannesburg 20
Totale 30.224
Nome #
CEFTRIAXONE THERAPY, INTESTINAL BETA-LACTAMASES AND INTERACTION WITH PROBIOTICS IN CHILDREN 725
Proprietà farmacocinetiche e farmacodinamiche di antibiotici nel trattamento locale di infezioni protesiche 394
Influenza del sito d’ infezione (pancreas) sulla farmacocinetica e farmacodinamica di piperacillina-tazobactam 285
Variability in the release of antibiotics from PMMA bone cement spacers 284
Medici a Verona: Indagine sui fattori di benessere/malessere dei professionisti veronesi 270
Analysis of intestinal microflora of autistic children before and after probiotic treatment. 268
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 262
I medici veronesi e le problematiche deontologiche della professione 262
Piperacillin-Tazobactam penetration into human pancreatic juice 247
Effetti del calcio policarbofil nel bambino con stipsi 243
Carbenicillina e Sulbenicillina. Studi di farmacocinetica nel ratto. 241
A simplified method for the evaluation of human flora in clinical practice. 240
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 235
Antibiotics penetration in human necrotizing pancreatitis (NP). 235
Health-promoting properties of new lactobacilli strains: in vivo models 234
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 229
Antibiotics and intestinal contents interaction 228
A new technique for evaluating the composition of faecal flora. 226
Safery and antibiotics concentrations in serum and urine after implantation of gentamicin-vancomycin-loaded spacers in patients with prosthetic joint infections 226
Effetti dei fluorochinoloni in linfociti di pazienti in trattamenti protratti. 225
Commercial probiotic products: evaluation of microbial content and nomenclature 223
Farmacocinetica e farmacodinamica di piperacillina–tazobactam in pazienti con fistola pancreatica esterna 222
Effect of dose on the intestinal concentrations of fluoroquinolones. Infection and Intensive care. Italian and British Perspectives 220
Diffusione ossea dell'associazione gentamicina-vancomicina da impianto in PMMA in osteomielite sperimentale 220
BACTERIAL ADHESION ON ANTIBIOTIC-LOADED POLYMETHYLMETHACRYLATE BONE CEMENT 219
[Antibacterial activity of rifampicin on faecal flora in rats] 216
Different probiotics and intestinal microflora in antibiotic treated children 216
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 214
[In vivo comparative evaluation of the activity of antibacterial drugs on aerobic fecal flora] 212
[Characterization of fosfomycin as a potential intestinal antibacterial agent. Studies in the rat] 211
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORMS AND DNA DAMAGE IN RAT. 211
Antibiotics and their interaction with intestinal contents. 210
Antibiotici e pancreas esocrino: interazioni. 210
Evaluations of CYP 3A 4/5 and DNA damage in rat enterocytes and in human and rat lymphocytes by fluoroquinolones 209
Diffusibilità di cefuroxim e cefoxitina in essudati pleurici ottenuti sperimentalmente nel ratto (pleurite da carragenina e da Bordetella pertussis). 205
Effect of pancreatic enzymes administration on intestinal ecosystem in patients with exocrine pancreatic insufficiency. Preliminary results 204
Rischio di nefrotossicità per terapia locale con cementi ossei antibiotati (aminoglicosidi e glicopeptidi) nelle infezioni protesiche. 204
Caratterizzazione della fosfomicina come potenziale antibatterico intestinale: studi nel ratto. 203
Rilascio locale dell’associazione gentamicina-vancomicina da chiodo endomidollare in osteomielite sperimentale 203
Fluoroquinolones effects on patients lymphocytes during prolonged treatments 202
Interazione itraconazolo-ciprofloxacina nel compartimento intestinale del ratto: dati preliminari 202
Sulfamidici e diaminopirimidine 202
Assessment of novel probiotic Lactobacillus casei strains strains for the production of functional dairy foods. 200
Antimicrobial activity of gentamicin and vancomycin combination in joint fluids after antibiotic-loaded cement spacer implantation in two-stage revision surgery. 198
Effect of ceftriaxone along with probiotics administrationon intestinal ecosystem and beta-lactamase activity 197
Effect of probiotics in the presence of antimicrobial therapy 196
FLUOROQUINOLONES: EFFECTS OF DOSE ON INTESTINAL PENETRATION, HEPATIC ISOFORM AND DNA DAMAGE IN RAT. 196
Bacterial faecal flora in healthy women of different ages. 195
EFFETTI DI FLUOROCHINOLONI IN LINFOCITI DI PAZIENTI IN TRATTAMENTI PROTRATTI. 195
Fluoroquinolones (FQs) effects on enterocytes and lymphocytes. 194
Antibacterial activity of the combination of uraemic sera and betalactam antibiotics. 194
Prophylaxis of P. carinii pneumonia (PCP). in HIV-infected patients with trimethoprim/sulfametoxazole (TMP/SMX) or dapsone (DDS) 193
Carbenicillina e sulbenicillina: studi di farmacocinetica nel ratto. 192
Bacterial adhesion on antibiotic-loaded polymethylmethacrylate bone cement 190
Itraconazole-ciprofloxacin interaction on the pharmacokinetics of the intestinal compartment: preliminary results in rats 189
Dose-effect of fluoroquinolones on intestinal penetration, hepatic isoforms and DNA damage in the rat 188
[Further research on the interference by oligosaccharide antibiotics in biosynthesis of the bacterial wall] 187
Bacterial flora composition and faecal enzymes in pre- and postmenopausal women with breast cancer. 187
Su meccanismo d'azione degli antibiotici oligosaccaridici. 186
Vancogenx-space for hip and knee: gentamicin and vancomycin levels in serum and urine from a multicenter trial 186
Health-promoting properties of new lactobacilli strains: in-vivo models 185
Attività antibatterica intestinale della meclociclina nel ratto. 183
Health promoting of new Lactobacilli strains: in-vivo models. 183
Effetti sistemici ed intestinali dei fluorochinoloni 182
Attività antimicrobica del siero di pazienti cancerosi ed interazioni farmacologiche con diversi farmaci antibatterici 180
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer 179
A serum antimicrobial activity of cancer patients and interaction with different antibacterial drugs. 178
Metronidazole (MZ) penetration into pancreatic juice (P5) and necrotic pancreatic tissue (NPT). 178
Alterazioni quantitative e qualitative nella flora fecale in ratti alimentati con dieta iperlipidica. 177
Antibiotic release from removed temporary hip spacers 177
A different behaviour of antibiotics in presence of fresh intestinal content in vitro. 176
Valutazione della compliance al dapsone (DDS) in pazienti in profilassi per PCP. 174
Changes in rat intestinal microflora following oral and parenteral administration of antimicrobial drugs 173
Microflora intestinale ed enzimi fecali in donne con fibromatosi uterina e tumore al seno. 172
Alterazioni dell’ecosistema inestinale da antibiotici. problemi e prospettive 172
Imipenem (IMP) penetration into pancreatic tissue during acute necrotizing form (NP). 172
Antibiotici e meccanismi di difesa dell'ospite 171
Caratterizzazione della fosfomicina. 171
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. 171
Osservazioni cliniche e sperimentali sul problema delle interazioni tra farmaci. 170
Behaviour of ciprofloxacin intestinal pharmacokinetics after different timing of Itraconazole administration 170
Commercial probiotic products: evaluation of microbial content and nomenclature. 168
Release of gentamicin and vancomycin alone and in combination from polymethylmethacrylate (PMMA) cement 168
Antibacterial interaction of cefuroxime and serum from uraemic patients. 166
Intestinal ecosystem and metabolic capacity in women with breast cancer 166
Effects of itraconazole on the pharmacokinetics of ciprofloxacin and the intestinal metabolizing system (CYP450 and P-glycoprotein) 166
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 166
Variability in the release of antibiotics from PMMA bone cement spacers 166
Interleuchina –4 e ossido nitrico nella pancreatite cronica umana. 165
Preliminary evaluation of probiotic properties of L. casei strains 165
Antibatterici e difese umorali aspecifiche dell'organismo. 165
Influence of the dose on the penetration of mezlocillin (M) into human pancreatic juice (P.J.). 165
Behaviour of antibiotics during human necrotizing pancreatitis. 164
Antibacterial activity of endogenous substances present in biological fluids. 164
Intestinal microflora and faecal enzymes in women with uterine leiomyoma and breast cancer. 163
Rilascio di antibiotici da spaziatori antibiotati nei fluidi di drenaggio 163
Different effect of pre-treatment with phenobarbital on transintestinal elimination of moxifloxacin and ciprofloxacin: preliminary data 163
Twice-weekly dapsone for primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1 infection: comparative efficacy and pharmacokinetic data. 162
Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriazone 162
Essudati pleurici e attività antibatterica del cefuroxim: azione in vivo e vitro 162
Totale 20.483
Categoria #
all - tutte 152.691
article - articoli 56.099
book - libri 0
conference - conferenze 82.969
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 13.623
Totale 305.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.428 0 0 0 0 113 87 54 127 96 81 226 644
2022/20235.647 458 439 602 884 593 1.220 60 474 517 50 270 80
2023/20242.230 137 253 165 370 190 251 83 234 38 48 226 235
2024/20255.757 431 562 212 914 357 49 213 326 944 276 348 1.125
2025/202613.824 1.130 689 971 1.965 3.354 1.377 1.461 721 930 764 198 264
2026/20275.693 741 457 1.097 2.896 502 0 0 0 0 0 0 0
Totale 48.788